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Abstract 
Background 
Childhood asthma is often preceded by early wheeze. Usually wheezing episodes 
are recorded retrospectively, which may induce recall bias. 
 
Aims and objectives 
The aim of this study was to investigate true positive recall of parent-reported 
wheeze at 1 year of age, its determinants and its implications for asthma and lung 
function at 6 years of age.  
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Methods 
The PASTURE (Protection Against Allergy – Study in Rural Environment) study fol-
lowed 880 children from rural areas in 5 European countries from birth up to age 6 
years. Wheeze symptoms in the first year were asked weekly. At age 6 parent-
reported asthma diagnosis was ascertained and lung function measurements were 
conducted. Correct parental recall of wheeze episodes at the end of the first year 
was assessed for associations with lung-function, asthma, and the asthma risk locus 
on chromosome 17q21. 
 
Results 
Parents correctly recalled wheeze after the first year in 54% of wheezers. This true 
positive recall was determined by number of episodes, timing of the last wheeze epi-
sode, and parental asthma. Independently from these determinants, true positive 
recall predicted asthma at age 6 years (odds ratio 4.54, 95%-confidence-interval (CI) 
[1.75-14.16]) and impaired lung-function (β=-0.62, 95% CI [-1.12; -0.13], p-
value=0.02). Associations were stronger in children with asthma risk SNPs on chro-
mosome 17q21. 
 
Conclusion 
Correct parental recall of wheezing episodes may reflect clinical relevance of early 
wheeze and its impact on subsequent asthma and lung function impairment. Ques-
tions tailored to parental perception of wheezing episodes may further enhance 
asthma prediction. 
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ABBREVIATIONS 
 
PASTURE Protection against allergy - 
study in rural environments 
ISAAC International Study of Allergy and 
Asthma in Childhood   
AMICS Asthma Multicenter Infants Cohort 
Study  
ALEX  Allergy and Endotoxin Study  
PARSIFAL  Prevention of Allergy Risk fac-
tors for Sensitization In children relating to 
Farming and Anthroposophic Lifestyle 
study  
ATS American Thoracic Society 
OR Odds Ratio 
HR hazards ratios 
β beta-estimates (linear regression) 
CI Confidence interval 
SNP Single nucleotide polymorphism 
IgE Immune globulin E 
FEV1 Forced expiratory volume in one 
second 
FVC Forced vital capacity 
GLI Global Lung-function Initiative 
LPS lipopolysaccharides 
IFN- γ Interferon- γ 
CH Switzerland 
FL Finland 
FR France 
DE Germany 
AT Austria 
Chr Chromosome 
C-section Cesarean section 
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Introduction 
With about one in three children affected in the first 3 years of life, wheeze is a 
common phenomenon in early childhood, implying a substantial burden on children, 
their caregivers, and healthcare resources (Europrevall) [1, 2].  
 
Suffering from recurrent or persistent early wheeze and exacerbations implies a 
higher risk for later asthma, airway hyper-responsiveness and decreased expiratory 
flow [3]. Particularly during the first year of life, wheeze exacerbations might set the 
stage for impaired airway function and persistent wheeze later in life [4, 5], whereas 
early diagnosis and intervention might prevent from detrimental lung-sequelae [4, 6]. 
Low interferon-γ (IFN-γ) levels has been shown to predict subsequent wheeze [7]. 
Wheeze phenotype classifications are often based on parental reports of age of on-
set, intensity, and frequency of symptoms combined with suspected trigger factors 
[8]. Awareness of symptoms, however, varies among parents. Likewise, physicians 
may interpret reports of wheezing episodes differently, particularly when devices to 
conduct confirmatory lung-function testing in young children are not available [9-11]. 
The PASTURE study offered the opportunity to analyse wheeze episodes pro- and 
retrospectively during the first year of life and to relate them to subsequent develop-
ment of asthma. The aims of the present analysis were (1) to compare the parent 
reported wheeze prevalence at 12 months against the cumulative wheeze preva-
lence derived from weekly diaries from 2 to 12 months without assumption on over- 
or underestimation, (2) to find determinants affecting parental recall of wheeze epi-
sodes, and (3) to estimate the implications of true positive recall at age 12 months on 
long-term respiratory health outcomes, i.e. asthma and impaired lung function at age 
6 years. 
 
Methods 
PASTURE is a prospective birth cohort study conducted in five European countries 
[12]. The study was approved by local research ethics committees, and written in-
formed consent was obtained from the children’s parents. Pregnant women living in 
rural areas were contacted during the last trimester of pregnancy, and 1133 children 
were recruited shortly after birth 
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Questionnaires at 2, 12 and 72 months were based on previously validated ques-
tionnaires from the International Study of Allergy and Asthma in Childhood 
(ISAAC)[13], the Asthma Multicenter Infants Cohort Study (AMICS), the Allergy and 
Endotoxin Study (ALEX)[14], the Prevention of Allergy Risk factors for Sensitization 
In children relating to Farming and Anthroposophic Lifestyle study (PARSIFAL)[15] 
and the American Thoracic Society (ATS)[16]. 
 
Information on wheezing episodes was collected via weekly diaries from the 8th until 
the 53rd week of life using the question “Within the last seven days, has your child 
had wheezing or whistling sounds while breathing?” meaning a “sound coming out of 
the breast, not from the nose” [17]. In the 12-month questionnaire, parents were 
asked how often their child had wheezed since the last home visit at age two 
months. Possible answer categories were “never”, “less than once a month”, “once a 
month” and “at least twice a month”. The four answer categories were dichotomized; 
children with any wheeze were classified as wheezers, children whose parents an-
swered “never” were classified as non-wheezers. 
 
Because of prospective and timely collection of data we used wheeze in the diaries 
as reference. The retrospectively collected information on wheeze using the 12-
month questionnaires was then categorized for true positive, true negative, false 
positive, and false negative recall (Table E1). 
 
Asthma was defined as either parent-reported physician’s diagnosis of asthma once 
or parent-reported physician’s diagnosis of obstructive bronchitis more than once 
when retrospectively asked in the 6 year follow-up questionnaire. 
 
Atopy was defined as inhalant sensitization as previously classified by a latent-class 
approach over the first 6 years [18]. 
Lung function measurements were conducted at age 6 years as previously validated 
[19]. FEV1/FVC z-score transformation based on GLI (Global Lung-function Initiative) 
equations [20, 21]. Genotyping included previously reported asthma risk alleles on 
chromosome 17q21 [17]. Interferon-γ (IFN-γ) production at 12 months was meas-
ured after 24 hours of incubation of peripheral blood mononuclear with lipopolysac-
charides [22]. 
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Statistical analyses were performed using R 3.3.2 (R Core Team, 2016). Mutually 
adjusted logistic regression models for true positive recall (versus false negative re-
call) and asthma, respectively, were established via backward elimination with level-
of-entry<0.2 and level-of-stay<0.05.  
 
After log-transformation and subtraction from the maximum value, IFN-γ levels were 
left-censored. Therefore associations with true positive recall were assessed by 
Kaplan-Meier-Estimation and Cox proportional hazards-models after confirmation of 
the proportional hazards-assumption by the Schönefeld Residuals-test. Estimates 
are reported as odds ratios (ORs), hazards ratios (HR), or beta-estimates (β) with 
corresponding 95% confidence intervals (CIs).  
 
Results 
Of all 1133 children primarily included in the PASTURE birth cohort, 880 children  
(78 %) had diary data on wheeze events from the 8th until the 53rd week of life and 
information on asthma status until six years of age and were thus included in the 
analysis population (Figure E1). Among the included children (n=880) there was a 
slight predominance of farm exposure, longer duration of breastfeeding, and parental 
education, whereas smoking during pregnancy was less common (Table E2). Within 
the analysis population, 611 children completed lung function measurements (Table 
E3). 
 
The weekly prevalence of wheeze ranged between 1% and 3% and peaked at about 
42 weeks; the proportion of concomitant rhinitis increased marginally (Figure 1). The 
cumulative incidence of wheeze until the first birthday was 35%. In 167 of all 307 
children wheezing ever during the first year (54%), parents recalled wheeze symp-
toms at the end of the first year correctly. Parents of 140 children (46%) did not recall 
wheeze episodes in the preceding year in the questionnaire at 12 months though 
they had reported episodes in the diaries (Figure 2A).  
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Determinants of true positive recall were parental asthma, total number of wheeze 
episodes within the first year of life, and a short time lag between completion of the 
one-year-questionnaire and the last wheeze episode (Table 1). Average duration of 
wheeze episodes was 4.2 days with no significant difference between children with 
true positive recall and children with false negative recall (Wilcoxon-test, p=0.37). 
Sensitivity analyses stratifying for sex and for concomitant rhinitis or excluding Aus-
tria (because of no case of asthma) supported the determinants of true positive recall 
albeit at varying effect size (Table E4). Medication for wheeze was reported only oc-
casionally (2.7 %) including antibiotics (n=15), mucolytics (n=9), inhalant corticoster-
oids (n=4), and other drugs (n=2) with a non-significant association with true positive 
recall (OR=1.77, CI 95% [0.59-5.32]). 
 
Asthma was reported in 70 children at age 6 (8.0%). When used as a cumulative 
measure, the yearly-asked question on asthma led to an overestimation of the asth-
ma prevalence with 21.7% and was not considered for further analyses. 
 
In the group with true positive recall, the risk of asthma was about 4-fold increased 
as compared to children without wheeze or false negative recall (Figure 2B). In gen-
eral, the association of asthma with true positive recall (OR=3.45 [1.59-7.51]) was 
stronger as the association of asthma with any wheeze in the first year in the diaries, 
i.e. true positive and false negative recall combined (OR=2.89 [1.76-4.79]). 
 
The association of true positive recall and asthma was neither explained by number 
of wheeze episodes (OR=1.06 [0.95-1.20]) nor by time lag from the last wheeze epi-
sode (OR=0.98 [0.94-1.03]). Besides true positive recall, only parental hay fever and 
being carrier of the asthma risk allele on chromosome 17q21 represented by the 
SNP rs7216389 emerged as additional asthma-predicting factors in our analysis 
population (Table 2). Associations were similar across the study centers (Table E5).  
The association of true positive recall with subsequent asthma was restricted to car-
riers of the17q21 risk allele (Figure 3). When considering this interaction from a dif-
ferent perspective, association of asthma risk and risk genotype was only seen in 
children with true positive recall of wheeze (OR=2.46 [0.95-6.39]), whereas asthma 
risk was unrelated to genotype in children with false negative recall (OR=1.07 [0.12-
9.75]). 
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Moreover, true positive recall was strongly associated with impaired lung function as 
determined by the FEV1/FVC-ratio at age 6 years (ß = -0.62 [-1.12; -0.13], Figure 4) 
independently from parental history of atopy (Table E6).  
 
Children with true positive recall produced about 50% higher IFN-γ levels upon in 
vitro stimulation with LPS as compared to children with false negative recall (p=0.04, 
Figure E2). 
 
Discussion 
When asked prospectively by weekly diaries, about one third of the parents reported 
at least one wheeze episode in their children during the first year of life; when asked 
retrospectively at 12 months, however, only half of them remembered those epi-
sodes at all. The parental ability to recall those wheezing episodes in their infant’s 
first year of life correctly was related to parental history of asthma, number of 
wheeze events during that one-year-period and only a short time lag since the last 
wheeze episode. In turn, true positive recall was associated with a higher risk of 
subsequent asthma and impaired lung function as compared to false negative recall. 
The association of true positive recall with asthma was restricted to the asthma risk 
genotype encoded on 17q21. 
 
Obviously parental observations on wheeze are susceptible to recall bias and vary 
with respect to disease severity, compliance, and socioeconomic background of the 
study participants [3, 13, 23]. In the current setting, however, we demonstrate that 
recall bias can be informative in itself.  
 
The reasons why parents recall wheeze episodes in their children differently may 
include previous knowledge and experience, cautiousness, health perception, and 
possibly the impressiveness or severity of the episode. Evidently, parents suffering 
from asthma themselves are more attentive to wheeze events in their children and 
might more likely recall wheezing episodes. Moreover, children with a family history 
of asthma might be affected by more serious wheeze events, which may present 
more impressively to any observer [24-26]. Likewise, a higher number of total 
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wheeze events during the first year of life and a short time lag from the last episode 
may enhance parental recall. 
 
Despite the rather unspecific questions on wheeze episodes, a strong association of 
true positive recall with subsequent asthma emerged as the main result of this anal-
ysis. This association was independent of all the above determinants for true positive 
recall, thereby suggesting that parents anticipate subsequent chronic disease from 
the way the wheeze episodes present. Unfortunately, more detailed information on 
wheeze episodes was not collected, thus we do not know why these episodes were 
kept in memory. At least, the mere duration of episodes and usage of wheeze medi-
cation within the first year were unrelated to true positive recall though reporting of 
medication was rather low and possibly incomplete. 
 
The predictive value of wheeze episodes in the first year of life has previously been 
attributed to the asthma risk genotype encoded on chromosome 17q21, whereas in 
the non-risk genotype early wheeze was unrelated to subsequent asthma [17, 27]. 
The current analysis refines this finding insofar as the interaction of genotype and 
early wheeze is restricted to wheeze episodes that parents recall. Children whose 
parents forgot wheeze episodes resembled non-wheezing children in their absent 
association of asthma and genotype. Vice versa, genetically determined more se-
vere forms of asthma may manifest early in life with conspicuous symptoms. Accord-
ingly, genetic testing for the asthma risk genotype on chromosome 17q21 might be 
advisable in children presenting with remarkable wheezing episodes. 
 
Functionally, the asthma risk genotype on chromosome 17q21 has been implied in 
enhanced susceptibility to virus infections and impaired antiviral immunity [28]. The 
latter might also be reflected by lower IFN-y levels upon stimulation with lipopolysac-
charides as seen in children with true positive recall. Moreover, wheeze often oc-
curred concomitantly with rhinitis; thus, also the frequency of wheeze episodes may 
indicate a partially compromised immune system [7, 29].  
 
The strong association of true positive recall with asthma was paralleled by the as-
sociation of true positive recall with a decreased FEV1/FVC ratio measured at age 6 
years. This may indicate that children with more severe wheeze symptoms are al-
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ready prone to deteriorating lung function later in life through incompletely healed 
injuries of pulmonary tissue or alteration of lung epithelial cell growth [4-6]. Alterna-
tively, causation might be reverse, and children born with compromised airway func-
tion might present with more severe symptoms [30].  
 
Current scientific knowledge favours early diagnosis and early medical treatment of 
asthma symptoms. This may enhance lung growth from the beginning, mitigate pro-
gression towards asthma, prevent from lung function impairment, and thus improve 
quality of life in the long run [6, 31]. However assessment of lung function in very 
young children is limited or can only be conducted in an incomplete manner [6], thus 
clinicians often have to rely on basic physical examination, family history, and paren-
tal report of symptoms. 
 
Though the quality of data collected via weekly diary questionnaires filled by parents 
is considered rather high and has been validated against the gold standard of medi-
cal records [32], we admit that the mere question on wheeze episodes as asked in 
the PASTURE study seems rather unspecific. Furthermore, a proper distinction be-
tween separate and ongoing wheeze episodes over several weeks was not possible 
based on the way of questioning within the weekly diary reports. These drawbacks 
might have led to an underestimation of the predictive value of parental report. Thus, 
in the future more detailed questions should be included in research questionnaires 
and standardized history taking. 
 
Another strength of the PASTURE study besides its longitudinal study design is the 
involvement of children from 5 different European countries, well depicting a profile 
of distinct European lifestyles. The associations of parental wheeze recall and later 
asthma were rather consistent over all study centers (I2<10%) and thus demonstrate 
reliability and generalizability of our results across various regions of Europe. 
 
This is remarkable since cross-cultural validity and comparability are hampered by 
language differences, and the terminology of wheeze in non-Anglophone countries 
might be difficult. In the German language, e.g., there is not even a colloquial term 
for “wheezing” [33]. Likewise, German-speaking physicians are somewhat reluctant 
to diagnose “asthma”; among others, they prefer the diagnosis “obstructive bronchi-
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tis”. This led to the definition of asthma as a physician’s diagnosis of asthma or re-
current obstructive bronchitis in the ISAAC study [13]. Originally this definition was 
established and validated against cold-air provocation in school-children [34], 
whereas in a prospective study such as PASTURE it would lead to overestimation of 
the asthma prevalence when used as a cumulative variable. This phenomenon again 
suggests that forgetting early episodes of obstructive bronchitis until school age 
seems justified; oblivion may transport unconscious information. 
 
In conclusion, our findings suggest that parents intuitively notice clinically relevant 
wheeze episodes in their children. This perception might contribute to a better prog-
nosis of asthma and impaired lung-function later on. Conversely, wheeze episodes 
without long lasting consequences are more likely forgotten. Parents might therefor 
be advised not to bother much about mild wheeze episodes. Concurrently, continu-
ous monitoring may run the risk of capturing irrelevant episodes and thus unsettling 
parents unnecessarily. Nevertheless, history taking should include more detailed 
questions on alarming wheeze episodes, as it could help identifying children who 
might benefit from immediate treatment, reduce need for emergency treatment, and 
enhance quality of life. Ultimately, this analysis demonstrates the value of skilful lis-
tening to parents reporting their children’s symptoms. 
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Tables 
 
Table 1: Determinants of true positive recall of wheeze epi-
sodes in children with wheeze in the first year as recorded 
in diaries (n=307) 
Determinants  Crude  
odds ratio 
Adjusted  
odds ratio 
Concomitant rhinitis 0.91 [0.50-1.64] - 
Timing of last wheeze episode (in weeks of age) 1.05 [1.03-1.07] 1.04 [1.01-1.06] 
Number of wheeze episodes 1.49 [1.26-1.76] 1.38 [1.17-1.65] 
Average duration of wheeze episodes (in days) 0.91 [0.74-1.12] - 
Number of cough episodes 1.09 [1.03-1.16] - 
Number of rhinitis episodes 1.03 [0.98-1.09] - 
Sex  1.56 [0.99-2.47] - 
Farming status 0.75 [0.48-1.18] - 
Mode of birth 1.61 [0.8-3.23] - 
Breastfeeding (>6 months) 1.12 [0.72-1.76] - 
Smoking in pregnancy 1.01 [0.53-1.91] - 
Older siblings 1.18 [0.73-1.91] - 
Parental hay fever 1.09 [0.69-1.71] - 
Parental asthma 2.3 [1.24-4.27] 2.46 [1.27-4.95] 
Parental atopic eczema 1.1 [0.5-2.4] - 
Parental atopy 1.32 [0.83-2.08] - 
Parental education 1.06 [0.67-1.67] - 
Having pets in the 4th year 0.71 [0.43-1.19] - 
Day care attendance in the first 3 years 1.44 [0.46-4.55] - 
Odds ratios are given with 95%-confidence intervals. For crude models, only deter-
minants with p-values <0.2 are listed. Adjusted models were established by back-
ward elimination.  
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Table 2: Associations of true positive recall of wheeze with 
an asthma diagnosis (n=880) 
Determinants Crude odds ratio Adjusted odds ratio 
True positive recall 3.45 [1.59-7.51] 4.54 [1.75-14.16] 
Sex 2.21 [1.31-3.74] - 
Farmer 0.56 [0.34-0.93] - 
Parental asthma 3.94 [2.3-6.73] - 
Parental hay fever 3.11 [1.83-5.3] 2.86 [1.23-7.09] 
Parental atopic eczema 4.08 [1.5-11.13] - 
Parental atopy 2.83 [1.61-4.97] - 
Chr 17q21 (rs7216389) 1.68 [1.12-2.52] 1.92 [1.05-3.61] 
Odds ratios are given with 95%-confidence intervals. For crude models, only deter-
minants with p-values <0.05 are listed. Adjusted models were established by back-
ward elimination.   
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Legends to figures 
 
Figure 1: Wheeze weekly in the 1st year of life 
 
Figure 2: True positive recall of wheeze episodes and subsequent 
asthma  
Information on wheeze based on weekly diary questionnaires or on the questionnaire 
at 1 year. True negatives are defined as no wheeze reported by both instruments. 
False positive means wheeze reported in the questionnaire at 1 year only. False 
negative recall means wheeze reported only in weekly diaries but not recalled in the 
questionnaire at 1 year. True positive recall are defined as wheeze reported by both 
instruments. The total number of children with data provided by both instruments 
was 880. 
 
Figure 3: Asthma risk stratified for true positive recall and geno-
types (CC, CT, TT) of asthma risk allele (rs7126389) on chromo-
some 17q21  
 
Figure 4: Lung function (FEV1/FVC) in children with false negative 
recall and true positive recall 
Given is a standard box-and-whiskers plot with boxes representing the inner quar-
tiles and whiskers extending to maximum and minimum values within 1.5 times the 
interquartile range.  
*P-values are based on an Anova and a post-hoc t-test. 
** FEV1/FVC z-score based on GLI (Global Lung-function Initiative) equations. 
 
Figure E1: Selection of the study population and timeline of the 
PASTURE study up to age 6 years 
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Figure E2: IFN-γ levels in children with true positive recall and false 
negative recall  
*to achieve normal distributed, left censored IFN-y values, original values were first 
log-tranformed and then subtracted from max. IFN-y  
HR=0.68, CI 95% [0.46-0.98]  
Proportional hazards assumption was previously confirmed (Schönefeld Residuals 
Test, p-value= 0.51) 
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